EQS-News: Heidelberg Pharma AG / Key word: Quarterly / Interim Statement
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024
25.04.2024 /.
EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
Victrex plc is a world leader in high-performance polymer solutions. In their Q1 2024 statement, they report a decline in revenue and volume but highlight progress in certain end-markets. They also discuss their financial position and cost actions. CEO Jakob Sigurdsson remains optimistic about the opportunity for progress in the future.
ProVen Growth and Income VCT plcInterim Management Statement for the nine months ended 30 November 2023 ProVen Growth and Income VCT plc presents an Interim Management Statement for the nine-month.
ProVen Growth and Income VCT plc: Interim Management Statement finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.